InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the detailed record of transactions filed by LEBEL FRANCOIS, Directeur Médical. Director active across 2 companies, notably SPECTRUM PHARMACEUTICALS INC. In total, 8 reports have been logged. Total volume traded: €94k. The latest transaction was disclosed on 21 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
0405,040 shares0
Common Stock, $0.001 par value
SEC:0001209191-22-039063:0·
€1,4821,205 shares@ €1.232.5% of flow
Common Stock, $0.001 par value
SEC:0001209191-22-023224:0·
€16,19025,130 shares@ €0.644227.0% of flow
Common Stock, $0.001 par value
SEC:0001209191-22-019341:0·
€8,35613,466 shares@ €0.620513.9% of flow
Common Stock, $0.001 par value
SEC:0001209191-22-012928:0·
€14,0217,363 shares@ €1.904341.3% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-064002·
€14,0217,363 shares@ €1.904323.4% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-064002:0·
€19,9265,821 shares@ €3.42358.7% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-042775·
€19,9265,821 shares@ €3.42333.2% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-042775:0·
8 of 8 declarations
About LEBEL FRANCOIS
François Lebel is the Chief Medical Officer of SPECTRUM PHARMACEUTICALS INC. In this role, he is responsible for the medical direction and clinical strategy of the company. SPECTRUM PHARMACEUTICALS INC. is committed to developing innovative treatments for serious diseases. François plays a key role in the strategic direction of medical initiatives.
